Novel Treatments for Mantle Cell Lymphoma: From Targeted Therapies to CAR T Cells-Reference-Cited by-同舟云学术

Novel Treatments for Mantle Cell Lymphoma: From Targeted Therapies to CAR T Cells

Published:2021-03-30 Issue:6 Volume:81 Page:669-684
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Wallace Danielle,Reagan Patrick M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40265-021-01497-y.pdf

Reference110 articles.

1. Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2017.

2. Smedby KE, Hjalgrim H. Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes. Semin Cancer Biol. 2011;21(5):293–8. https://doi.org/10.1016/j.semcancer.2011.09.010.

3. Romaguera JE, Medeiros LJ, Hagemeister FB, Fayad LE, Rodriguez MA, Pro B, et al. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer. 2003;97(3):586–91. https://doi.org/10.1002/cncr.11096.

4. Dreyling M, Campo E, Hermine O, Jerkeman M, Le Gouill S, Rule S, et al. Newly diagnosed and relapsed mantle cell lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv62–71. https://doi.org/10.1093/annonc/mdx223.

5. Jain AG, Chang CC, Ahmad S, Mori S. Leukemic non-nodal mantle cell lymphoma: diagnosis and treatment. Curr Treat Opt Oncol. 2019;20(12):85. https://doi.org/10.1007/s11864-019-0684-8.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and <i>TP53</i>/p53 – a Nordic Lymphoma Group study;Haematologica;2023-08-31

2. Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell Lymphoma;Cells;2022-10-27

3. Effect of CD20 signaling pathway on lymphoma cell proliferation, invasion and related protein IDO/AHR expression;Food Science and Technology;2022